4//SEC Filing
TardiMed Sciences LLC 4
Accession 0000905718-20-000959
CIK 0001504167other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:38 PM ET
Size
9.0 KB
Accession
0000905718-20-000959
Insider Transaction Report
Form 4
TardiMed Sciences LLC
10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2020-09-14$1.03/sh−455$469→ 5,625,271 total - Sale
Common Stock, par value $0.001 per share
2020-09-16$1.03/sh−100,694$103,695→ 5,437,517 total - Sale
Common Stock, par value $0.001 per share
2020-09-15$1.03/sh−87,060$89,550→ 5,538,211 total
Footnotes (2)
- [F1]The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.0200 to $1.0400, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F2]The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.0200 to $ 1.0500, inclusive. The reporting person undertakes to provide to Timber, any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
Documents
Issuer
Timber Pharmaceuticals, Inc.
CIK 0001504167
Entity typeother
IncorporatedCT
Related Parties
1- filerCIK 0001800690
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 5:38 PM ET
- Size
- 9.0 KB